ADBiotech Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	12,114	3,913	638.53	3,015	1,179	1,195
Short-Term Investments	630	630	630	630	4,547	120
Trading Asset Securities	2,904	6,926	410.72	5,769	2,901	1,465
Cash & Short-Term Investments	15,648	11,470	1,679	9,414	8,628	2,781
Cash Growth	408.27%	583.01%	-82.16%	9.11%	210.28%	-2.17%
Accounts Receivable	1,562	1,961	2,930	1,596	1,873	3,497
Other Receivables	227.94	109.3	108.46	8.07	47.67	3.28
Receivables	4,174	5,989	3,039	1,604	2,321	3,500
Inventory	2,065	2,293	2,375	2,265	2,952	2,106
Prepaid Expenses	72.79	1,031	152.11	16.83	59.27	81.21
Other Current Assets	3,077	70.84	1,144	117.63	163.87	204.67
Total Current Assets	25,037	20,854	8,390	13,417	14,123	8,672
Property, Plant & Equipment	10,408	10,182	11,061	10,312	10,319	10,287
Long-Term Investments	2,769	1,785	1,923	1,585	6,491	1,878
Goodwill	-	-	704.45	1,126	-	-
Other Intangible Assets	28.14	31.69	898.15	1,029	2.4	5.11
Long-Term Accounts Receivable	0	0	-	-	-	0
Other Long-Term Assets	15,684	15,555	98.42	623.51	83	117.09
Total Assets	53,925	48,407	23,074	28,093	31,018	20,959

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	1,429	1,701	1,669	250.65	386.05	1,116
Accrued Expenses	210.73	417.87	336.03	212.78	250.12	341.01
Short-Term Debt	9,861	12,904	6,985	9,142	9,543	9,147
Current Portion of Long-Term Debt	781.64	831.64	653.96	399.08	166.56	773.78
Current Portion of Leases	237.17	37.98	60.72	89.38	21.09	19.92
Other Current Liabilities	9,781	13,749	3,797	1,174	1,426	1,229
Total Current Liabilities	22,301	29,641	13,501	11,268	11,793	12,626
Long-Term Debt	3,862	3,027	3,859	3,513	3,012	3,179
Long-Term Leases	138.29	0.77	413.32	466.24	28.1	49.18
Pension & Post-Retirement Benefits	76.56	57.35	47	71.92	-	-
Long-Term Deferred Tax Liabilities	319.66	303.68	483.29	205.32	-	-
Other Long-Term Liabilities	-	0	0	0	-	-
Total Liabilities	26,697	33,031	18,304	15,525	14,833	15,854

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	13,475	8,180	4,570	4,570	4,570	3,847
Additional Paid-In Capital	49,033	35,617	25,557	27,257	27,257	18,293
Retained Earnings	-33,346	-27,672	-24,381	-16,431	-13,574	-16,270
Comprehensive Income & Other	-908.25	-802.69	-909.44	-2,004	-2,068	-763.03
Total Common Equity	28,254	15,323	4,837	13,393	16,185	5,106
Minority Interest	-1,796	-1,783	-1,862	-2,545	-	-
Shareholders' Equity	27,228	15,377	4,771	12,569	16,185	5,106
Total Liabilities & Equity	53,925	48,407	23,074	28,093	31,018	20,959

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	14,880	16,802	11,972	13,610	12,771	13,168
Net Cash (Debt)	767.95	-5,332	-10,292	-4,196	-4,143	-10,388
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	45.22	-443.97	-1126.04	-459.08	-410.96	-1351.57
Filing Date Shares Outstanding	26.95	16.36	9.14	9.14	9.14	7.69
Total Common Shares Outstanding	26.95	16.36	9.14	9.14	9.14	7.69
Working Capital	2,736	-8,788	-5,111	2,149	2,330	-3,954
Book Value Per Share	1048.37	936.60	529.16	1465.20	1770.73	663.67
Tangible Book Value	28,226	15,291	3,234	11,237	16,183	5,100
Tangible Book Value Per Share	1047.33	934.66	353.83	1229.37	1770.47	663.00
Land	5,446	5,446	5,321	3,868	3,868	641.06
Buildings	3,995	4,061	4,192	4,323	4,455	4,586
Machinery	438.42	489.7	967.43	1,411	1,729	2,201
Construction In Progress	-	25.6	-	14.4	117.47	2,784